Picture of Cizzle Biotechnology Holdings logo

CIZ Cizzle Biotechnology Holdings News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

REG - Cizzle Biotechnology - Holding(s) in Company

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240916:nRSP2205Ea&default-theme=true

RNS Number : 2205E  Cizzle Biotechnology Holdings PLC  16 September 2024

 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the
 FCA in Microsoft Word format if possible)i

 1a. Identity of the issuer or the underlying issuer of existing shares to                                                                                                               Cizzle Biotechnology Holdings PLC
 which voting rights are attachedii:
 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X"
 if appropriate)
 Non-UK issuer
 2. Reason for the notification (please mark the appropriate box or boxes with
 an "X")
 An acquisition or disposal of voting rights                                                                                                                                                                                                        X
 An acquisition or disposal of financial instruments
 An event changing the breakdown of voting rights
 Other (please specify)
 3. Details of person subject to the notification obligation

Name

 City and country of registered office (if applicable)

                                                                                                                                                              Jonathan Niall Roberts

                                                                                                                                                              St Peter Port, Guernsey
 4. Full name of shareholder(s) (if different from 3.)

 Name
 City and country of registered office (if applicable)
 5. Date on which the threshold was crossed or reachedvi:                                                                                                                                13/09/2024
 6. Date on which issuer notified (DD/MM/YYYY):                                                                                                                                          13/09/2024
 7. Total positions of person(s) subject to the notification obligation
                                                                            % of voting rights attached to shares (total of 8. A)  % of voting rights through financial instruments (total of 8.B 1 + 8.B 2)        Total of both in % (8.A + 8.B)  Total number of voting rights of issuervii
 Resulting situation on the date on which threshold was crossed or reached  3.53%                                                                                                                                   3.53%                           14,000,136
 Position of previous notification (if applicable)

TR-1: Standard form for notification of major holdings

 8. Notified details of the resulting situation on the date on which the
 threshold was crossed or reached
 A: Voting rights attached to shares
 Class/type of             Number of voting rights                                                                    % of voting rights

shares
 ISIN code (if possible)
                           Direct                                      Indirect                                       Direct                                      Indirect

                           (Art 9 of Directive 2004/109/EC) (DTR5.1)   (Art 10 of Directive 2004/109/EC) (DTR5.2.1)   (Art 9 of Directive 2004/109/EC) (DTR5.1)   (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
                           14,000,136                                                                                 3.53%

 SUBTOTAL 8. A             14,000,136                                                                                 3.53%

 

 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
 (DTR5.3.1.1 (a))

 Type of financial instrument  Expiration date  Exercise/ Conversion Period  Number of voting rights that may be acquired if the instrument is  % of voting rights

                            exercised/converted.

                                                SUBTOTAL 8. B 1

 

 B 2: Financial Instruments with similar economic effect according to Art.
 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

 Type of financial instrument  Expiration date  Exercise/ Conversion Period  Physical or cash settlement  Number of voting rights  % of voting rights

                                                                             SUBTOTAL 8. B 2

 

 9. Information in relation to the person subject to the notification
 obligation (please mark the applicable box with an "X")

 Person subject to the notification obligation is not controlled by any natural
 person or legal entity and does not control any other undertaking(s) holding
 directly or indirectly an interest in the (underlying) issuerxiii

 Full chain of controlled undertakings through which the voting rights and/or
 the

financial instruments are effectively held starting with the ultimate
 controlling natural person or legal entityxiv (please add additional rows as
 necessary)

 X
 Namexv  % of voting rights if it equals or is higher than the notifiable threshold  % of voting rights through financial instruments if it equals or is higher  Total of both if it equals or is higher than the notifiable threshold
                                                                                     than the notifiable threshold

 10. In case of proxy voting, please identify:
 Name of the proxy holder
 The number and % of voting rights held
 The date until which the voting rights will be held

 11. Additional information

 Place of completion         St Peter Port, Guernsey
 Date of completion          13/09/2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  HOLUORWRSBUKAAR

Recent news on Cizzle Biotechnology Holdings

See all news